Medicon Valley Academy and Norgenta North German Life Science Agency agree on cooperation in two projects
The aim of the project is to facilitate academic institutions to work on therapeutic molecules according to industrial standards and on industrial scale. The Medicon Valley Academy will support the project partners in winning academic institutions from the Øresund region for this European project. "With this agreement we will pave the way for integrating the expertise of the Øresund region's first-class research facilities into the LinkUp project" stresses Dr. Kathrin Adlkofer, Norgenta's managing director, subsequent to signing the agreement. Prof. Per Belfrage, Chairman of the Medicon Valley Academy Board, appreciates the cooperation. "The cooperation with Norgenta will, due to this agreement, be started with two already concrete projects being very important for both regions."
The second project is the application of the Øresund region as hosting region of the Innovative Medicine Initiative (IMI) secretariat, an initiative presented by the European Union together with the EFPIA (European Federation of Pharmaceutical Industry and Associations). IMI is a European technology platform aiming not only at the faster development of safe and effective drugs. It also aims at the revitalisation of the European Scientific Community in the field of Biomedicals.
Medicon Valley Academy and Norgenta have, due to their commitment in the meta network ScanBalt, a considerable interest to settle this secretariat within the ScanBalt region. In future, both regions will exchange information concerning important projects and aim at cooperating beyond these first two concrete projects.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.